Cyclopharm Ltd (CYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 27,573 | 26,339 | 23,219 | 17,705 | 14,676 |
| Cost of Goods | 9,640 | 10,256 | 7,441 | 5,042 | 3,963 |
| Gross Profit | 17,933 | 16,084 | 15,778 | 12,662 | 10,713 |
| Operating Expenses | 32,457 | 26,108 | 23,412 | 19,615 | 19,200 |
| Operating Income | -14,525 | -10,025 | -7,634 | -6,953 | -8,487 |
| Interest Expense | 36 | 24 | 67 | 17 | 18 |
| Other Income | 1,489 | 5,859 | 1,672 | 2,622 | 2,661 |
| Pre-tax Income | -13,071 | -4,190 | -6,030 | -4,347 | -5,844 |
| Income Tax | 126 | 511 | 582 | 693 | 200 |
| Net Income Continuous | -13,198 | -4,701 | -6,612 | -5,040 | -6,044 |
| Net Income | $-13,198 | $-4,701 | $-6,612 | $-5,040 | $-6,044 |
| EPS Basic Total Ops | -0.13 | -0.05 | -0.07 | -0.06 | -0.08 |
| EPS Basic Continuous Ops | -0.13 | -0.05 | -0.07 | -0.06 | -0.08 |
| EPS Diluted Total Ops | -0.13 | -0.05 | -0.07 | -0.06 | -0.08 |
| EPS Diluted Continuous Ops | -0.13 | -0.05 | -0.07 | -0.06 | -0.08 |
| EBITDA(a) | $-11,559 | $-3,227 | $-5,031 | $-3,572 | $-4,916 |